Modification of pharmacokinetics of norfloxacin following oral administration of curcumin in rabbits
Investigation was carried out in adult New Zealand white rabbits to study the influence of curcumin pre-treatment on pharmacokinetic disposition of norfloxacin following single oral administration. Sixteen rabbits were divided into two groups of eight each consisting of either sex. Animals in group-...
Saved in:
Published in | Journal of veterinary science (Suwŏn-si, Korea) Vol. 10; no. 4; pp. 293 - 297 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
대한수의학회
01.12.2009
The Korean Society of Veterinary Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Investigation was carried out in adult New Zealand white rabbits to study the influence of curcumin pre-treatment on pharmacokinetic disposition of norfloxacin following single oral administration. Sixteen rabbits were divided into two groups of eight each consisting of either sex. Animals in group-Ⅰ were administered norfloxacin (100 mg/kg body weight p.o), while animals in group-Ⅱ received similar dose of norfloxacin after pre-treatment with curcumin (60 mg/kg body weight per day, 3 days, p.o). Blood samples were drawn from the marginal ear vein into heparin-coated vials at 0 (zero time), 5, 10, 15, 30 min and 1, 2, 4, 6, 12 and 24 h post-treatment. Plasma norfloxacin concentrations were determined by high performance liquid chromatography. The plasma concentration-time profile of norfloxacin was adequately described by a one-compartment open model. The pharmacokinetic data revealed that curcumin-treated animals had significantly (p less-than or equal to 0.05) higher area under the plasma concentration-time curve and area under the first moment of plasma drug concentration-time curve. Prior treatment of curcumin significantly (p less-than or equal to 0.05) increased elimination half-life and volume of distribution of norfloxacin. Further treatment with curcumin reduced loading and maintenance doses by 26% and 24% respectively. |
---|---|
Bibliography: | L70 2010003970 G704-001401.2009.10.4.005 |
ISSN: | 1229-845X 1976-555X |
DOI: | 10.4142/jvs.2009.10.4.293 |